As you heard and saw in the previous step, drug development is a very complex and challenging process that is associated with many specifications.

We invite you to read the following article by Irene Kuepfer and Christian Burri to further deepen your understanding of clinical trials conduct in sub-Saharan Africa:

«Reflections on clinical research in sub-Saharan Africa».

Please read pages 1-3 and 12-13. If you want to delve deeper, you can read the entire article.

The article stresses the need of clinical research guidelines and regulations adaption to the context in low- and middle-income countries. After this introduction on challenges of drug development in Africa, we would like to invite you to think about the following questions:

• How can clinical trials’ operations be improved in resource-constrained settings?
• What can be learned from trials’ operations in resource-constrained settings?

References

Küpfer I, Burri C. Reflections on clinical research in sub-Saharan Africa. International Journal for Parasitology [Internet]. 2009 [cited 1 December 2021]; 39 (9): 947-954. Available from: https://edoc.unibas.ch/19330/